These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28899690)

  • 21. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice.
    Barrier M; Lacroix-Lamandé S; Mancassola R; Auray G; Bernardet N; Chaussé AM; Uematsu S; Akira S; Laurent F
    J Infect Dis; 2006 May; 193(10):1400-7. PubMed ID: 16619188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.
    Gorla SK; McNair NN; Yang G; Gao S; Hu M; Jala VR; Haribabu B; Striepen B; Cuny GD; Mead JR; Hedstrom L
    Antimicrob Agents Chemother; 2014; 58(3):1603-14. PubMed ID: 24366728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel treatment strategies and drugs in development for cryptosporidiosis.
    Chavez MA; White AC
    Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
    Robinson P; Martin P; Garza A; D'Souza M; Mastrangelo MA; Tweardy D
    J Parasitol; 2008 Oct; 94(5):1150-4. PubMed ID: 18576802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental treatment using combined Fructus psoraleae and dihydroartemisinin in mouse cryptosporidiosis].
    Chen YF; Qin YH; Zheng LL; Dai XD; Ren YX; Nie DP; Cui Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Feb; 26(1):67-9. PubMed ID: 18637590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dicationic furans inhibit development of Cryptosporidium parvum in HSD/ICR suckling Swiss mice.
    Blagburn BL; Drain KL; Land TM; Moore PH; Kinard RG; Lindsay DS; Kumar A; Shi J; Boykin DW; Tidwell RR
    J Parasitol; 1998 Aug; 84(4):851-6. PubMed ID: 9714224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Existing Drug Vorinostat as a New Lead Against Cryptosporidiosis by Targeting the Parasite Histone Deacetylases.
    Guo F; Zhang H; McNair NN; Mead JR; Zhu G
    J Infect Dis; 2018 Mar; 217(7):1110-1117. PubMed ID: 29300993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms.
    Carryn S; Schaefer DA; Imboden M; Homan EJ; Bremel RD; Riggs MW
    J Parasitol; 2012 Feb; 98(1):199-204. PubMed ID: 21787211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pomegranate (Punica granatum) peel is effective in a murine model of experimental Cryptosporidium parvum.
    Al-Mathal EM; Alsalem AM
    Exp Parasitol; 2012 Jul; 131(3):350-7. PubMed ID: 22580265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model.
    Rueda C; Fenoy S; Simón F; Del Aguila C
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1150-2. PubMed ID: 18160525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral dosing of neonatal mice with sucrose reduces infection with Cryptosporidium parvum.
    Harp JA
    J Parasitol; 1999 Oct; 85(5):952-5. PubMed ID: 10577733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.
    Van Voorhis WC; Hulverson MA; Choi R; Huang W; Arnold SLM; Schaefer DA; Betzer DP; Vidadala RSR; Lee S; Whitman GR; Barrett LK; Maly DJ; Riggs MW; Fan E; Kennedy TJ; Tzipori S; Doggett JS; Winzer P; Anghel N; Imhof D; Müller J; Hemphill A; Ferre I; Sanchez-Sanchez R; Ortega-Mora LM; Ojo KK
    Vet Parasitol; 2021 Jan; 289():109336. PubMed ID: 33418437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of mangiferin against Cryptosporidium parvum in a neonatal mouse model.
    Perrucci S; Fichi G; Buggiani C; Rossi G; Flamini G
    Parasitol Res; 2006 Jul; 99(2):184-8. PubMed ID: 16547730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.
    Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA
    J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of
    Buckner FS; Ranade RM; Gillespie JR; Shibata S; Hulverson MA; Zhang Z; Huang W; Choi R; Verlinde CLMJ; Hol WGJ; Ochida A; Akao Y; Choy RKM; Van Voorhis WC; Arnold SLM; Jumani RS; Huston CD; Fan E
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo.
    Huang K; Yang S
    Biol Trace Elem Res; 2002; 90(1-3):261-72. PubMed ID: 12666840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved efficacy of dinitroaniline analogs for use as anti-cryptosporidial drugs.
    Mead JR; Benbow JW; Garmon D; Stewart J
    J Eukaryot Microbiol; 1999; 46(5):62S-63S. PubMed ID: 10519250
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of in vitro and in vivo activity of benzindazole-4,9-quinones against Cryptosporidium parvum.
    Kayser O; Waters WR; Woods KM; Upton SJ; Keithly JS; Laatsch H; Kiderlen AF
    J Antimicrob Chemother; 2002 Dec; 50(6):975-80. PubMed ID: 12461020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected gamma-interferon knockout mice.
    Smith LM; Bonafonte MT; Mead JR
    J Parasitol; 2000 Apr; 86(2):300-7. PubMed ID: 10780549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.